Alterity Therapeutics (ATHE) Change in Cash (2016 - 2019)
Alterity Therapeutics (ATHE) posted quarterly Change in Cash of -$1.6 million for Q4 2019, up 68.41% year-over-year from -$952916.1 in Q4 2018, and up 68.41% quarter-over-quarter from -$5.1 million in Q4 2018.
Alterity Therapeutics (ATHE) Change in Cash (2016 - 2019) Analysis & Trends
Alterity Therapeutics' Change in Cash history runs 4 years deep, the most recent figure standing at -$1.6 million for Q4 2019.
- In Q4 2019, Change in Cash rose 68.41% year-over-year to -$1.6 million; the TTM figure through Dec 2019 stood at -$8.2 million (down 72.08% YoY), while the FY2025 annual figure was $13.3 million, up 692.99% from the prior year.
- Change in Cash for Q4 2019 stood at -$1.6 million, up from -$5.1 million in the prior quarter.
- The five-year high for Change in Cash was -$598231.8 in Q4 2016, with the low at -$5.1 million in Q4 2018.
- The 4-year median for Change in Cash is -$1.3 million (2017), against an average of -$2.1 million.
- The sharpest annual moves came in 2018 and 2019: Change in Cash slumped 444.27% in 2018, then surged 68.41% in 2019.
- Alterity Therapeutics' Change in Cash stood at -$598231.8 in 2016, then tumbled by 56.04% to -$933486.7 in 2017, then plunged by 444.27% to -$5.1 million in 2018, then soared by 68.41% to -$1.6 million in 2019.
- Business Quant data shows ATHE's Change in Cash at -$1.6 million in Q4 2019, -$5.1 million in Q4 2018, and -$933486.7 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -1.60 Mn |
| Dec 31, 2018 | -5.08 Mn |
| Dec 31, 2017 | -933,486.69 |
| Dec 31, 2016 | -598,231.82 |